Accelerating Oncology Drug FDA Submission with Project Management Services Case Study Accelerating Oncology Drug FDA Submission with Project Management Services Discover how Certara’s dedicated project management and pharmacometric support helped an emerging biotech company fast-track…CertaraJuly 2, 2025
The Medicine Maker: The Biosimulation Generation Press Coverage The Medicine Maker: The Biosimulation Generation The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…Danielle PillsburyJuly 1, 2025
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…CertaraJune 30, 2025
How Model-informed drug development rescue projects from a risky situation Case Study How Model-informed drug development rescue projects from a risky situation Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…CertaraJune 26, 2025
Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning Publication Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…Danielle PillsburyJune 19, 2025
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara Webinar From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara CertaraJune 18, 2025
How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook Blog How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook June 16, 2025 Editor’s note: This is the third of four articles in our series…Simona ColucciJune 16, 2025
Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year Announcement Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year Certara wins Great Place to Work Certification, with 85% of employees praising workplace culture, innovation,…CertaraJune 13, 2025
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Webinar Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis Danielle PillsburyJune 11, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer Publication Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…CertaraJune 8, 2025